The genetic hallmark of CML is the presence of the Philadelphia chromosome (Ph) and the formation of a fusion oncogene known as BCR::ABL1 [2]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.